Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02943317
Title Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Verastem, Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Defactinib

Avelumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.